This company has been marked as potentially delisted and may not be actively trading. NASDAQ:OCDX Ortho Clinical Diagnostics (OCDX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Ortho Clinical Diagnostics Stock (NASDAQ:OCDX) 30 days 90 days 365 days Advanced Chart Get OCDX alerts:Sign Up Key Stats Today's Range$17.63▼$17.6350-Day Range$17.63▼$17.6352-Week Range$16.04▼$22.99Volume5,400 shsAverage Volume1.24 million shsMarket Capitalization$3.92 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOrtho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.Read More… Receive OCDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ortho Clinical Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address OCDX Stock News HeadlinesOrtho Clinical Diagnostics Holdings Plc Share ChatAugust 30, 2024 | lse.co.ukNovacyt: Innovative Clinical DiagnosticsAugust 22, 2023 | investing.comVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.May 24, 2025 | Porter & Company (Ad)First long COVID treatment clinical trials from NIH getting underwayAugust 9, 2023 | cbsnews.comClinical Diagnostics Global Market Report 2023: Sector to Reach $124.7 Billion by 2028 at a CAGR of 8.56%March 18, 2023 | finance.yahoo.comClinical Diagnostics Mass Spectrometry Market Brief Analysis By Top Leading CompaniesFebruary 25, 2023 | marketwatch.comClinical Diagnostics Market 2023 is FASTEST-GROWING in [ Medical Devices & Consumables ] Sector till 2028February 25, 2023 | marketwatch.comClinical Diagnostics Market Size in 2023 Business Forecast 2028 by Discovering LATEST TRENDSFebruary 22, 2023 | marketwatch.comSee More Headlines OCDX Stock Analysis - Frequently Asked Questions How were Ortho Clinical Diagnostics' earnings last quarter? Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) issued its earnings results on Wednesday, November, 3rd. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.07. The business earned $522.50 million during the quarter, compared to analyst estimates of $485.36 million. Ortho Clinical Diagnostics had a positive trailing twelve-month return on equity of 41.71% and a negative net margin of 0.02%. Read the conference call transcript. When did Ortho Clinical Diagnostics IPO? Ortho Clinical Diagnostics (OCDX) raised $1.5 billion in an IPO on Thursday, January 28th 2021. The company issued 70,000,000 shares at $20.00-$23.00 per share. J.P. Morgan, BofA Securities, Goldman Sachs, Barclays and Morgan Stanley acted as the underwriters for the IPO and Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler, ING, Macquarie Capital, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright & Co., Ramirez & Co. and Siebert Williams Shank were co-managers. What other stocks do shareholders of Ortho Clinical Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ortho Clinical Diagnostics investors own include Meta Platforms (META), WPP (WPP), Garmin (GRMN), Li Auto (LI), Advanced Micro Devices (AMD), Kinsale Capital Group (KNSL) and Company Calendar Last Earnings11/03/2021Today5/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolNASDAQ:OCDX CIK1828443 Webwww.orthoclinicaldiagnostics.com Phone908-218-8000FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio21.77 P/E Growth1.66Net Income$-54,300,000.00 Net Margins-0.02% Pretax Margin1.38% Return on Equity41.71% Return on Assets5.10% Debt Debt-to-Equity Ratio4.91 Current Ratio1.89 Quick Ratio1.29 Sales & Book Value Annual Sales$2.04 billion Price / Sales1.92 Cash Flow$2.28 per share Price / Cash Flow7.73 Book Value$1.99 per share Price / Book8.86Miscellaneous Outstanding Shares222,585,000Free FloatN/AMarket Cap$3.92 billion OptionableNot Optionable Beta1.32 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:OCDX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! Save 85% on Weiss Crypto Investor!President Trump just made his first big crypto move … Announcing the creation of a national strategic reser...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ortho Clinical Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ortho Clinical Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.